In a recent study, XPO1 was shown to be expressed in a significant proportion of pancreatic cancer, and increased expression correlates with both survivin expression and increased proliferative activity, suggesting that selective inhibitors of nuclear export may be effective against pancreatic cancer [33]. The gene discussed is XPO1; the disease is familial pancreatic carcinoma.